inositol has been researched along with Diseases, Metabolic in 13 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Several studies have evaluated the effect of inositol supplementation on lipid profiles among population with metabolic diseases; however, the findings are controversial." | 8.98 | The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. ( Akbari, M; Asemi, Z; Kolahdooz, F; Lankarani, KB; Ostadmohammadi, V; Peymani, P; Tabrizi, R, 2018) |
| "Several studies have evaluated the effect of inositol supplementation on lipid profiles among population with metabolic diseases; however, the findings are controversial." | 4.98 | The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. ( Akbari, M; Asemi, Z; Kolahdooz, F; Lankarani, KB; Ostadmohammadi, V; Peymani, P; Tabrizi, R, 2018) |
| "Insulin resistance is becoming an increasingly studied target for therapy, most evidence stemming from the time-honored metformin use." | 2.66 | Current treatment for polycystic ovary syndrome: focus on adolescence. ( Catellani, C; Cirillo, F; Dauriz, M; Lazzeroni, P; Moghetti, P; Sartori, C; Street, ME, 2020) |
| "Inositol deregulation has been found in a number of conditions mechanistically and epidemiologically associated to high-glucose diets or altered glucose metabolism." | 2.55 | Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders. ( Bizzarri, M; Cucina, A; Dinicola, S; Minini, M; Unfer, V; Verna, R, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Street, ME | 1 |
| Cirillo, F | 1 |
| Catellani, C | 1 |
| Dauriz, M | 1 |
| Lazzeroni, P | 1 |
| Sartori, C | 1 |
| Moghetti, P | 1 |
| De Diego, MV | 1 |
| Gómez-Pardo, O | 1 |
| Groar, JK | 1 |
| López-Escobar, A | 1 |
| Martín-Estal, I | 1 |
| Castilla-Cortázar, I | 1 |
| Rodríguez-Zambrano, MÁ | 1 |
| Morgante, G | 1 |
| Massaro, MG | 1 |
| Di Sabatino, A | 1 |
| Cappelli, V | 1 |
| De Leo, V | 1 |
| Dinicola, S | 1 |
| Minini, M | 1 |
| Unfer, V | 1 |
| Verna, R | 1 |
| Cucina, A | 1 |
| Bizzarri, M | 1 |
| Tabrizi, R | 1 |
| Ostadmohammadi, V | 1 |
| Lankarani, KB | 1 |
| Peymani, P | 1 |
| Akbari, M | 1 |
| Kolahdooz, F | 1 |
| Asemi, Z | 1 |
| Ge, X | 1 |
| Xu, XY | 1 |
| Feng, CH | 1 |
| Wang, Y | 1 |
| Li, YL | 1 |
| Feng, B | 1 |
| Odinak, MM | 1 |
| Ianishevskiĭ, SN | 1 |
| Tsygan, NV | 1 |
| Golokhvastov, SIu | 1 |
| Vozniuk, IA | 1 |
| Trufanov, AG | 1 |
| Rodrigues, AC | 1 |
| Ferraz-Filho, JR | 1 |
| Torres, US | 1 |
| da Rocha, AJ | 1 |
| Muniz, MP | 1 |
| Souza, AS | 1 |
| Goloni-Bertollo, EM | 1 |
| Pavarino, ÉC | 1 |
| Napoli, C | 1 |
| Sessa, M | 1 |
| Infante, T | 1 |
| Casamassimi, A | 1 |
| LEVY, M | 1 |
| BECKMANN, R | 1 |
| Levine, J | 1 |
| Grisaru, N | 1 |
| Vetter, K | 1 |
| Täufel, K | 1 |
6 reviews available for inositol and Diseases, Metabolic
| Article | Year |
|---|---|
Current treatment for polycystic ovary syndrome: focus on adolescence.
Topics: Adolescent; Contraceptives, Oral, Hormonal; Female; Gene-Environment Interaction; Humans; Hypoglycem | 2020 |
Therapeutic approach for metabolic disorders and infertility in women with PCOS.
Topics: Androgen Antagonists; Anovulation; Clomiphene; Contraceptives, Oral, Hormonal; Female; Gonadotropins | 2018 |
Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders.
Topics: Biological Availability; Humans; Inositol; Metabolic Diseases; Nutritional Status | 2017 |
The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Female; Humans; Inositol; Lipid Meta | 2018 |
Unraveling framework of the ancestral Mediator complex in human diseases.
Topics: Animals; Cardiovascular Diseases; Catechols; Humans; Inositol; Mediator Complex; Metabolic Diseases; | 2012 |
[Inositol treatment in medicine].
Topics: Animals; Humans; Inositol; Inositol Phosphates; Mental Disorders; Metabolic Diseases; Models, Biolog | 1996 |
1 trial available for inositol and Diseases, Metabolic
| Article | Year |
|---|---|
[The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke].
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Brain; Glucose; Humans; Inositol; Lactates; Magnetic R | 2013 |
6 other studies available for inositol and Diseases, Metabolic
| Article | Year |
|---|---|
Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study.
Topics: Adolescent; Adult; Blood Glucose; Contraceptives, Oral, Combined; Female; Glycated Hemoglobin; Human | 2020 |
Relationships among serum C-reactive protein, receptor for advanced glycation products, metabolic dysfunction, and cognitive impairments.
Topics: Adult; Aged; Aspartic Acid; C-Reactive Protein; Cholesterol; Choline; Cognition Disorders; Female; H | 2013 |
Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
Topics: Adolescent; Aspartic Acid; Brain; Case-Control Studies; Child; Child, Preschool; Choline; Creatine; | 2015 |
[Effect of choline and inositol on metabolic disorders found in animals with various types of steatosis].
Topics: Animals; Choline; Fatty Liver; Inositol; Metabolic Diseases | 1957 |
[PATHOGENIC ELEMENTS AND THERAPEUTIC EXPERIENCES CONCERNING ERB'S PROGRESSIVE MUSCULAR DYSTROPHY].
Topics: Adenosine Triphosphate; Albumins; Ascorbic Acid; Calcium, Dietary; Choline; Diet; Diet Therapy; Frui | 1964 |
[Cereals in dietetics].
Topics: Calcium, Dietary; Carbohydrates; Diet; Diet Therapy; Edible Grain; Humans; Inositol; Intestinal Abso | 1971 |